Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

CNS Drugs

Issue 4/2010

Content (6 Articles)

Review Article

Defining and Measuring Functional

Tracy L. Greer, Benji T. Kurian, Madhukar H. Trivedi

Review Article

Childhood Medulloblastoma

Laura J. Klesse, Daniel C. Bowers

Original Research Article

Cholinesterase Inhibitors as Adjunctive Therapy in Patients with Schizophrenia and Schizoaffective Disorder

Salma R. I. Ribeiz, Débora P. Bassitt, Jony A. Arrais, Renata Avila, David C. Steffens, Cássio M. C. Bottino

Original Research Article

For What Diagnoses Are Psychotropic Medications Being Prescribed?

Tami L. Mark

Adis Drug Profile

Pramipexole Extended Release

Claudine M. Chwieduk, Monique P. Curran

Adis Drug Evaluation

OROS® Hydromorphone Prolonged Release

Natalie J. Carter, Gillian M. Keating

Mar 10
Issue: 3/2010
May 10
Issue: 5/2010

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more